Similarly, seropositivity for IgG1 was not associated with secondary treatment efficacy measures, whereas IgG3 responses were associated with a ≥35% reduced odds of having a PC1⁄2 of ≥5 hours and having parasitemia on day 3 after treatment (Table 2). Here, IGHG3 is linked to parasitic infectious disease.